Search Results for "Ocimum Biosolutions New Campus"
Original Source: Ocimum Biosolutions Ltd.
Ocimum Biosolutions is a life sciences R&D enabling company with three focus areas, BioIT, Microarrays and Research services. The Microarray division of Ocimum has been recently acquired from MWG Biotech. These include Catalog “OciChip”, Custom “OciChip” and microarray services.The BioIT division of Ocimum Biosolutions provides key, ready to use reliable, cost-effective software solutions for the biotech/pharma industry with a suite of products such as Biotracker™, Toxchek™, Pharmatracker™, Ge...
Matching Channels
The Top 100 Pharmaceutical Companies
The Top 100 Pharmaceutical Companies, determined by total sales in 2011 - see below for 2010 and 2009: They are listed in descending order with the sales in 2011 in $ million; Pfizer ...
Matching News
Emergent BioSolutions: Company profile
Return to bigbiotech list Summary Website: Emergent BioSolutions Headquarters: Maryland , USA SEC Link: Emergent Biosolutions Subsidiary Companies: BioPort Emergent Product Development Epic Bio Micro...
Emergent BioSolutions to Present at Cowen and Company 33rd Annual Health Care Conference
Emergent BioSolutions Inc. (NYSE: EBS) announced today that a member of the company’s senior management team will provide a corporate overview presentation at the Cowen and Comp...
Emergent BioSolutions plans $35M buyback
Emergent BioSolutions Inc. will buy back up to $35 million of its shares, the drug developer said Monday.The Rockville, Md. company says that it will fund the repurchases with working capital.It had...
Emergent BioSolutions secures funding from BARDA for anthrax vaccine
Emergent BioSolutions of Rockville, Md., has reached an agreement with the Biomedical Advanced Research and Development Authority (BARDA) to conduct a non-interference study to be used to support a po...
Emergent BioSolutions provides update on TRU-016 Phase 1b study
Emergent BioSolutions Inc. today announced its decision to expand the protocol for its ongoing Phase 1b, single arm, open label study (Protocol 16009) evaluating the safety and efficacy of TRU-016 in...
Emergent BioSolutions to Participate in Piper Jaffray’s 24th Annual Healthcare Conference
Emergent BioSolutions Inc. (NYSE: EBS) announced today that a member of the company’s senior management team will lead a discussion, which may involve recent business dev...
Emergent BioSolutions Inc. (NYSE: EBS) has announced that it will hold its Annual Meeting of Stockholders on Thursday, May 23, 2013 beginning at 9:00 AM Eastern at the Sheraton Ro...
Emergent BioSolutions commences NuThrax Phase 2 trial in anthrax infection
Emergent BioSolutions Inc. today announced the initiation of a Phase 2 clinical trial for NuThrax (Anthrax Vaccine Adsorbed with CPG 7909 Adjuvant), also known as AV7909, with the dosing of the first...
Matching PubMed Articles
Ethnopharmacological relevance: Ocimum basilicum belongs to the genus Ocimum (Lamiaceae). Many species of this genus including O. basilicum have been traditionally used for the treatment of a variety...
In vivo anti-inflammatory activities of Ocimum suave in mice.
Ocimum suave has been used in the Ethiopian traditional medicine to relieve pain, fever, inflammation and other disease conditions.
Rapid synthesis of silver nanoparticles using dried medicinal plant of basil.
Plants respond to heavy metal stress by metal complexation process like production of phytochelations or by other metal chelating peptides. In this paper we report the synthesis of silver nanoparticle...
The antioxidant effects of Ocimum sanctum in experimental streptozocin-induced diabetic rats was evaluated in this study. Streptozocin, 55 mg kg(-1) body weight, was injected intraperitoneally onc...
The leaf extract of Ocimum sanctum was used as a reducing agent for the synthesis of platinum nanoparticles from an aqueous chloroplatinic acid (H(2)PtCl(6)·6H(2)O). A greater conversion of platinum...